PARDES BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2020 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pardes Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2020 to Q2 2023.
  • Pardes Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$10.8M, a 61% increase year-over-year.
  • Pardes Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2023 was -$76.1M, a 1.6% decline year-over-year.
  • Pardes Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$96.6M, a 151% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 -$10.8M +$16.9M +61% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$17.8M +$3.64M +17% Mar 31, 2023 10-Q 2023-08-04
Q4 2022 -$24.2M -$9.88M -68.8% Dec 31, 2022 10-K 2023-03-14
Q3 2022 -$23.3M -$11.8M -103% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$27.6M -$19.5M -240% Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$21.4M -$16.9M -374% Mar 31, 2022 10-Q 2023-08-04
Q4 2021 -$14.3M Dec 31, 2021 10-K 2023-03-14
Q3 2021 -$11.5M -$11.5M -1115404% Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$8.14M Jun 30, 2021 10-Q 2022-11-07
Q1 2021 -$4.52M Mar 31, 2021 10-Q 2022-11-07
Q3 2020 -$1.03K* Sep 30, 2020 10-Q/A 2021-11-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.